Imagine you are evaluating a major Indian conglomerate that holds a 60% stake in a listed retail subsidiary. When you download the consolidated P/L statement, you see the massive top-line revenue of the retail unit added...
You are deep into your quarterly review of a leading Indian pharmaceutical company, comparing its growth potential against a domestic software major. You notice the pharma firm records substantial R&D expenditure as...
You are deep into your quarterly review of a leading Indian pharmaceutical company, comparing its growth potential against a domestic software major. You notice the pharma firm records substantial R&D expenditure as...
Imagine you are reviewing the annual report of a manufacturing firm that recently divested a loss-making subsidiary. The P/L statement shows a significant 'Exceptional Item' loss before taxes, which reduced the reported...
Imagine you are sitting at your desk, tasked with initiating coverage on a mid-cap manufacturing firm in India. You have successfully navigated the multi-step P/L account, identifying the core operating margins and...
Imagine you are analyzing two rival manufacturing firms in the Indian chemical sector. Company A reports significantly higher operating margins than Company B, despite having similar revenue growth and production...
Imagine you are reviewing the annual report of a mid-sized Indian manufacturing firm. You notice that while the company’s absolute Net Profit has grown at a healthy 12% CAGR, your model's projected Return on Capital...
Picture yourself preparing an initiation report on a mid-cap manufacturing firm listed on the NSE. The income statement displays a healthy net profit margin, yet your DCF model valuation keeps flagging a terminal value...
As you sit down to build a DCF model for a mid-cap manufacturing firm, you notice their revenue growth is exceptional. However, when reconciling the Profit and Loss statement with the Cash Flow statement, you see a...
Imagine you are reviewing the annual report of an infrastructure firm listed on the NSE. Your valuation model shows strong EBITDA margins, yet you notice a persistent increase in interest coverage ratios alongside...